AUROBINDO PHARMA LTD vs DR. REDDY S LABORATORIES
A side-by-side comparison of AUROBINDO PHARMA LTD (AUROPHARMA) and DR. REDDY S LABORATORIES (DRREDDY) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, DR. REDDY S LABORATORIES leads AUROPHARMA vs DRREDDY on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability13
- Growth11
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
DRREDDY takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
EvenThree-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
DRREDDY takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- − ["Stock is trading at 2.52 times its book value", "The company has delivered a poor sales growth of 6.32% over past five years.", "Company has a low return on equity of 10.8% over last 3 years.", "Company might be capitalizing the interest cost"]
- + ["Company's working capital requirements have reduced from 85.1 days to 67.8 days"]
- − ["Dividend payout has been low at 13.2% of profits over last 3 years"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.